Your browser doesn't support javascript.
loading
Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp, Katie; Moran, Bruce; O'Brien, Timothy; Brennan, Donal; Crown, John; Sheahan, Kieran; Cotter, Maura Bríd.
Afiliación
  • Beauchamp K; Department of Histopathology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. katie.beauchamp@hse.ie.
  • Moran B; Department of Histopathology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
  • O'Brien T; Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin 7, Ireland.
  • Brennan D; Systems Biology Ireland, UCD School of Medicine, Belfield, Dublin4, Ireland.
  • Crown J; UCD Gynaecological Oncology Group, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
  • Sheahan K; Department of Medical Oncology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
  • Cotter MB; Department of Histopathology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Cancer Metastasis Rev ; 42(4): 1189-1200, 2023 12.
Article en En | MEDLINE | ID: mdl-37394540
ABSTRACT
Carcinoma of unknown primary (CUP) is a heterogeneous group of metastatic cancers in which the site of origin is not identifiable. These carcinomas have a poor outcome due to their late presentation with metastatic disease, difficulty in identifying the origin and delay in treatment. The aim of the pathologist is to broadly classify and subtype the cancer and, where possible, to confirm the likely primary site as this information best predicts patient outcome and guides treatment. In this review, we provide histopathologists with diagnostic practice points which contribute to identifying the primary origin in such cases. We present the current clinical evaluation and management from the point of view of the oncologist. We discuss the role of the pathologist in the diagnostic pathway including the control of pre-analytical conditions, assessment of sample adequacy, diagnosis of cancer including diagnostic pitfalls, and evaluation of prognostic and predictive markers. An integrated diagnostic report is ideal in cases of CUP, with results discussed at a forum such as a molecular tumour board and matched with targeted treatment. This highly specialized evolving area ultimately leads to personalized oncology and potentially improved outcomes for patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Desconocidas / Carcinoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Metastasis Rev Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Desconocidas / Carcinoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Metastasis Rev Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Irlanda